Abstract B13: Leveraging cloud-based computational resources for gene fusion discovery with potential clinical implications for pediatric solid tumor patients. Read more about Abstract B13: Leveraging cloud-based computational resources for gene fusion discovery with potential clinical implications for pediatric solid tumor patients.
Abstract A59: Sequencing identifies diagnostically relevant alterations in pediatric solid tumor patients. Read more about Abstract A59: Sequencing identifies diagnostically relevant alterations in pediatric solid tumor patients.
Abstract A27: An apoptosis-based screen for targeted agents in rhabdomyosarcoma reveals potential combination therapies. Read more about Abstract A27: An apoptosis-based screen for targeted agents in rhabdomyosarcoma reveals potential combination therapies.
Abstract A06: The added value of examining germline variants in a precision cancer therapy study. Read more about Abstract A06: The added value of examining germline variants in a precision cancer therapy study.
Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Read more about Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk.
Abstract B40: Minimal mutational determinants of human squamous cell carcinoma. Read more about Abstract B40: Minimal mutational determinants of human squamous cell carcinoma.
Abstract PR14: A multiscale map of recurrently mutated systems in cancer. Read more about Abstract PR14: A multiscale map of recurrently mutated systems in cancer.
Abstract PHB03: A hierarchical model of DNA repair inferred from omics-scale genetic interaction data reveals the dynamics of DNA damage induction. Read more about Abstract PHB03: A hierarchical model of DNA repair inferred from omics-scale genetic interaction data reveals the dynamics of DNA damage induction.
Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Read more about Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.
IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment. Read more about IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
